Stem cell technology promises better grafts:
This article was originally published in Clinica
The US company Progenitor has received a patent for its technology for processing blood stem cells capable of developing into blood or blood vessel cells. These could be used in bone marrow transplantation, vascular grafts, coatings and other therapeutic applications. The Menlo Park, California-based firm grows stem cells from the yolk sac, a tissue that appears very briefly in the early development of mammals.